Cargando…

Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection

BACKGROUND: Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the most severe form of viral hepatitis. However, its exact global disease burden remains largely obscure. We aim to establish the global epidemiology, infection mode-stratified disease progression, and clinical o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Zhijiang, Zhang, Shaoshi, Ou, Xumin, Li, Shan, Ma, Zhongren, Wang, Wenshi, Peppelenbosch, Maikel P, Liu, Jiaye, Pan, Qiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184909/ https://www.ncbi.nlm.nih.gov/pubmed/31778167 http://dx.doi.org/10.1093/infdis/jiz633

Ejemplares similares

Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus
por: Miao, Zhijiang, et al.
Publicado: (2018)

Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context
por: Li, Pengfei, et al.
Publicado: (2020)

Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
por: Li, Yunlong, et al.
Publicado: (2021)

2’-Fluoro-2’-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705
por: Yu, Peifa, et al.
Publicado: (2020)

The global epidemiology of hepatitis E virus infection: A systematic review and meta‐analysis
por: Li, Pengfei, et al.
Publicado: (2020)

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific
por: Xu, Lei, et al.
Publicado: (2014)

Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections
por: Qu, Changbo, et al.
Publicado: (2019)

Estimating the global prevalence of hepatitis E virus in swine and pork products
por: Li, Pengfei, et al.
Publicado: (2021)

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
por: Qu, Changbo, et al.
Publicado: (2017)

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Estimating the burden and modeling mitigation strategies of pork-related hepatitis E virus foodborne transmission in representative European countries
por: Ji, Yunpeng, et al.
Publicado: (2021)

Errors in translational decoding: tRNA wobbling or misincorporation?
por: Ou, Xumin, et al.
Publicado: (2019)

Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus
por: Ikram, Aqsa, et al.
Publicado: (2017)

Potential association between COVID-19 mortality and health-care resource availability
por: Ji, Yunpeng, et al.
Publicado: (2020)

Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
por: Wang, Wenshi, et al.
Publicado: (2017)

Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks
por: Li, Pengfei, et al.
Publicado: (2023)

cGAS-STING effectively restricts murine norovirus infection but antagonizes the antiviral action of N-terminus of RIG-I in mouse macrophages
por: Yu, Peifa, et al.
Publicado: (2021)

The Interplay between Host Innate Immunity and Hepatitis E Virus
por: Li, Yang, et al.
Publicado: (2019)

Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
por: Li, Pengfei, et al.
Publicado: (2021)

Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis
por: Liu, Jiaye, et al.
Publicado: (2019)

LGR5 marks targetable tumor-initiating cells in mouse liver cancer
por: Cao, Wanlu, et al.
Publicado: (2020)

Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-Analyses
por: Ma, Zhongren, et al.
Publicado: (2020)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Remodeling of the gut microbiome during Ramadan-associated intermittent fasting
por: Su, Junhong, et al.
Publicado: (2021)

Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
por: Wang, Wenhui, et al.
Publicado: (2016)

Hepatitis D: advances and challenges
por: Miao, Zhijiang, et al.
Publicado: (2022)

Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids
por: Hakim, Mohamad S., et al.
Publicado: (2018)

Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma
por: Ma, Buyun, et al.
Publicado: (2018)

Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
por: Li, Juan, et al.
Publicado: (2017)

The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7
por: Chen, Sunrui, et al.
Publicado: (2019)

Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010
por: Rosenberg, Eli S., et al.
Publicado: (2017)

Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth
por: Li, Meng, et al.
Publicado: (2020)

Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids
por: Li, Pengfei, et al.
Publicado: (2022)

Deciphering Tumour Microenvironment of Liver Cancer through Deconvolution of Bulk RNA-Seq Data with Single-Cell Atlas
por: Zhang, Shaoshi, et al.
Publicado: (2022)

PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
por: Yin, Yuebang, et al.
Publicado: (2017)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Hepatitis E virus infection activates NOD‐like receptor family pyrin domain‐containing 3 inflammasome antagonizing interferon response but therapeutically targetable
por: Li, Yang, et al.
Publicado: (2021)

The biological process of lysine‐tRNA charging is therapeutically targetable in liver cancer
por: Zhang, Ruyi, et al.
Publicado: (2020)

6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling
por: Yin, Yuebang, et al.
Publicado: (2018)

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
por: Wang, Yining, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9bhlfma2drv13et1oc7vqd4i85